The role of adjuvant chemotherapy in the treatment of uterine sarcoma patients.

@article{Tre1990TheRO,
  title={The role of adjuvant chemotherapy in the treatment of uterine sarcoma patients.},
  author={G{\"o}khan T{\"o}re and Erkan Topuz and N Bilce and Işık Aslay and Maktav Dinçer and A Elgin},
  journal={European journal of gynaecological oncology},
  year={1990},
  volume={11 4},
  pages={307-12}
}
41 uterine sarcoma patients completed their post-operative adjuvant treatment at Istanbul University, Oncology Institute. Of these patients 23 had pelvic irradiation (RT group) and 18 had pelvic irradiation plus chemotherapy (RT + CT group). The 3 year survival rates of the two adjuvant treatment arms were 36% (RT group) and 66% (RT + CT group) (0.05… CONTINUE READING